{"id":"https://openalex.org/W2139401596","doi":"https://doi.org/10.1200/jco.1998.16.10.3264","title":"Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the Parma trial.","display_name":"Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the Parma trial.","alternate_titles":[],"publication_year":1998,"publication_date":"1998-10-01","ids":{"openalex":"https://openalex.org/W2139401596","doi":"https://doi.org/10.1200/jco.1998.16.10.3264","mag":"2139401596","pmid":"https://pubmed.ncbi.nlm.nih.gov/9779700"},"language":"en","primary_location":{"id":"doi:10.1200/jco.1998.16.10.3264","doi":"https://doi.org/10.1200/jco.1998.16.10.3264","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.1998.16.10.3264","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2139401596"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011779828","display_name":"Cesare Guglielmi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I861853513","display_name":"Sapienza University of Rome","ror":"https://ror.org/02be6w209","country_code":"IT","type":"education","lineage":["https://openalex.org/I861853513"]}],"countries":["IT"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C Guglielmi","raw_affiliation_strings":["Dipartimento di Biotecnologie Cellulari ed Ematologia, Universit\u00e0 La Sapienza, Rome, Italy. guglielmi@bce.med.uniroma1.it"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dipartimento di Biotecnologie Cellulari ed Ematologia, Universit\u00e0 La Sapienza, Rome, Italy. guglielmi@bce.med.uniroma1.it","institution_ids":["https://openalex.org/I861853513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103345321","display_name":"Fr\u00e9d\u00e9r\u00edc Gomez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"F Gomez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105348558","display_name":"Thierry O. Philip","orcid":"https://orcid.org/0009-0007-7979-6847","observed_orcids":["https://orcid.org/0009-0007-7979-6847"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"T Philip","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043162057","display_name":"Anton Hagenbeek","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A Hagenbeek","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065465503","display_name":"Maurizio Martelli","orcid":"https://orcid.org/0009-0003-5564-3046","observed_orcids":["https://orcid.org/0009-0003-5564-3046"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M Martelli","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022526324","display_name":"Catherine Sebban","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C Sebban","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034473496","display_name":"Noel Jean Milpied","orcid":"https://orcid.org/0000-0002-5177-014X","observed_orcids":["https://orcid.org/0000-0002-5177-014X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"N Milpied","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050300241","display_name":"D Bron","orcid":"https://orcid.org/0000-0002-1634-1104","observed_orcids":["https://orcid.org/0000-0002-1634-1104"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D Bron","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046436694","display_name":"Jean-Yves Y. Cahn","orcid":"https://orcid.org/0000-0002-2356-7101","observed_orcids":["https://orcid.org/0000-0002-2356-7101"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J Y Cahn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109946206","display_name":"Reinier Somers","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R Somers","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002972322","display_name":"Pieter Sonneveld","orcid":"https://orcid.org/0000-0002-0808-2237","observed_orcids":["https://orcid.org/0000-0002-0808-2237"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P Sonneveld","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086620890","display_name":"Christian Gisselbrecht","orcid":"https://orcid.org/0000-0001-8079-3589","observed_orcids":["https://orcid.org/0000-0001-8079-3589"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C Gisselbrecht","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001539044","display_name":"Hans van der Lelie","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"H Van Der Lelie","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5042986036","display_name":"Franck Chauvin","orcid":"https://orcid.org/0000-0001-6595-820X","observed_orcids":["https://orcid.org/0000-0001-6595-820X"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"F Chauvin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":3.9055,"has_fulltext":false,"cited_by_count":175,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.93622544,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":92,"max":99},"biblio":{"volume":"16","issue":"10","first_page":"3264","last_page":"3269"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/time-to-relapse","display_name":"time to relapse","score":0.9449999928474426},{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":0.890999972820282},{"id":"https://openalex.org/keywords/aggressive-lymphoma","display_name":"aggressive lymphoma","score":0.8999999761581421},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8930000066757202},{"id":"https://openalex.org/keywords/salvage-therapy","display_name":"salvage therapy","score":0.6430000066757202},{"id":"https://openalex.org/keywords/dhap-regimen","display_name":"DHAP regimen","score":0.7599999904632568},{"id":"https://openalex.org/keywords/lactate-dehydrogenase","display_name":"lactate dehydrogenase","score":0.8159999847412109},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9089999794960022},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9940000176429749},{"id":"https://openalex.org/keywords/patient-stratification","display_name":"patient stratification","score":0.7490000128746033}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9216607809066772},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5783842206001282},{"id":"https://openalex.org/C2781214270","wikidata":"https://www.wikidata.org/wiki/Q4692282","display_name":"Aggressive lymphoma","level":4,"score":0.5455566644668579},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5365756750106812},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.47635436058044434},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.13839709758758545}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003561","descriptor_name":"Cytarabine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":"Q000532","qualifier_name":"radiotherapy","is_major_topic":false},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016016","descriptor_name":"Proportional Hazards Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016026","descriptor_name":"Bone Marrow Transplantation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1200/jco.1998.16.10.3264","doi":"https://doi.org/10.1200/jco.1998.16.10.3264","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.1998.16.10.3264","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:9779700","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9779700","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","raw_type":"Clinical Trial"},{"id":"pmh:oai:pure.eur.nl:openaire_cris_publications/073ae458-c31c-4928-adea-9d6cc95ad844","doi":null,"is_oa":false,"landing_page_url":"https://pure.eur.nl/en/publications/073ae458-c31c-4928-adea-9d6cc95ad844","pdf_url":null,"source":{"id":"https://openalex.org/S4306401266","display_name":"EUR Research Repository (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Guglielmi, C, Gomez, F, Philip, T, Hagenbeek, A, Martelli, M, Sebban, C, Milpied, N, Bron, D, Cahn, JY, Somers, R, Sonneveld, P, Gisselbrecht, C, Van Der Lelie, H & Chauvin, F 1998, 'Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the parma trial', Journal of Clinical Oncology, vol. 16, no. 10, pp. 3264-3269.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:eur:oai:pure.eur.nl:publications/073ae458-c31c-4928-adea-9d6cc95ad844","doi":null,"is_oa":false,"landing_page_url":"https://pure.eur.nl/en/publications/073ae458-c31c-4928-adea-9d6cc95ad844","pdf_url":null,"source":{"id":"https://openalex.org/S4306401266","display_name":"EUR Research Repository (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Clinical Oncology, 16(10), 3264 - 3269. American Society of Clinical Oncology","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:dipot.ulb.ac.be:2013/60295","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/60295","pdf_url":null,"source":{"id":"https://openalex.org/S4306401063","display_name":"D\u00e9p\u00f4t institutionnel de l'Universit\u00e9 libre de Bruxelles (Universit\u00e9 Libre de Bruxelles)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I132053463","host_organization_name":"Universit\u00e9 Libre de Bruxelles","host_organization_lineage":["https://openalex.org/I132053463"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of clinical oncology, 16 (10","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:iris.uniroma1.it:11573/247504","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11573/247504","pdf_url":null,"source":{"id":"https://openalex.org/S4377196107","display_name":"IRIS Research product catalog (Sapienza University of Rome)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9907000064849854,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W1580788756","https://openalex.org/W1819949687","https://openalex.org/W1834664850","https://openalex.org/W1841420516","https://openalex.org/W1881397173","https://openalex.org/W1895128059","https://openalex.org/W1911320760","https://openalex.org/W1914133119","https://openalex.org/W1979300931","https://openalex.org/W1997353354","https://openalex.org/W2013642593","https://openalex.org/W2139984188","https://openalex.org/W2225927535","https://openalex.org/W2231983599","https://openalex.org/W2255094305","https://openalex.org/W2263814165","https://openalex.org/W2301583383","https://openalex.org/W2313423582","https://openalex.org/W2338377114","https://openalex.org/W2339293928","https://openalex.org/W2339381415","https://openalex.org/W2468228608","https://openalex.org/W2605539363","https://openalex.org/W3024436806"],"related_works":["https://openalex.org/W1533253784","https://openalex.org/W390069474","https://openalex.org/W1931321618","https://openalex.org/W1998091329","https://openalex.org/W2923896514","https://openalex.org/W1987040691","https://openalex.org/W4386278198","https://openalex.org/W2095191779","https://openalex.org/W2073407890"],"abstract_inverted_index":{"PURPOSE:":[0],"The":[1,42,204],"purpose":[2],"of":[3,12,35,45,68,107,202,206,221,235,242,256,259],"this":[4],"study":[5,205],"was":[6,60,71],"to":[7,14,58,73,101,156,170,223,246,251,261],"investigate":[8],"the":[9,29,33,54,192,218],"prognostic":[10,133,181,207,219],"value":[11,134,220],"time":[13,34,222,255],"relapse":[15,59,80,129,171,177,224,247,258],"in":[16,135,191],"188":[17],"adult":[18],"patients":[19,47,76,83,253],"with":[20,90,104,130],"intermediate-":[21],"or":[22,237],"high-grade":[23,262],"non-Hodgkin's":[24,263],"lymphoma":[25],"(NHL)":[26],"included":[27],"on":[28],"Parma":[30,55],"trial":[31],"at":[32,128,176,254],"their":[36],"first":[37,257],"relapse.":[38,87],"PATIENTS":[39],"AND":[40],"METHODS:":[41],"median":[43],"follow-up":[44],"these":[46],"is":[48],"102":[49],"months":[50,70],"after":[51,199,239],"registration":[52],"onto":[53],"study.":[56],"Time":[57,169,245],"calculated":[61],"from":[62,81],"initial":[63],"diagnosis,":[64],"and":[65,92,111,118,158,173,213,230],"a":[66,131],"cutoff":[67],"12":[69],"used":[72,250],"separate":[74],"77":[75],"defined":[77,84],"as":[78,85],"early":[79,91],"111":[82],"late":[86,93],"RESULTS:":[88],"Patients":[89],"relapses":[94],"had":[95,179],"significantly":[96],"different":[97,119],"overall":[98,197,210],"response":[99,198,236],"rates":[100,122],"salvage":[102],"therapy":[103],"two":[105,200,240],"courses":[106,201,241],"dexamethasone,":[108],"high-dose":[109],"cytarabine,":[110],"cisplatin":[112],"(DHAP;":[113],"40%":[114],"v":[115,124],"69%;":[116],"P=.00007)":[117],"8-year":[120],"survival":[121,211,215],"(13%":[123],"29%;":[125],"P=.00001).":[126],"Features":[127],"negative":[132],"univariate":[136],"analysis":[137],"were":[138,167],"higher":[139],"than":[140,149,162],"normal":[141],"lactic":[142],"dehydrogenase":[143],"(LDH)":[144],"levels,":[145],"tumor":[146,184],"size":[147,185],"greater":[148],"5":[150],"cm,":[151],"Ann":[152],"Arbor":[153],"stages":[154],"III":[155],"IV,":[157],"Karnofsky":[159],"score":[160],"less":[161],"80%.":[163],"Therefore,":[164],"multivariate":[165],"analyses":[166],"performed.":[168],"(P=.001)":[172],"LDH":[174],"levels":[175],"(P=.003)":[178],"independent":[180,234],"value,":[182],"whereas":[183],"did":[186],"not":[187],"reach":[188],"statistical":[189],"significance":[190],"logistic":[193],"model":[194],"that":[195],"predicted":[196],"DHAP.":[203,243],"factors":[208],"for":[209,228,232],"(OS)":[212],"progression-free":[214],"(PFS)":[216],"confirmed":[217],"(P":[225],"<":[226],".0001":[227],"OS":[229],"P=.005":[231],"PFS)":[233],"treatment":[238],"CONCLUSION:":[244],"may":[248],"be":[249],"stratify":[252],"intermediate":[260],"lymphoma.":[264]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2139401596","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":10},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":15}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
